PharmaLundensis AB operates as a pharmaceutical company in Sweden. It is conducting clinical research, which has completed Phase I and Phase IIa clinical stages for developing drug for the treatment of chronic obstructive pulmonary disease. The company was founded in 2006 and is based in Lund, Sweden.
pharmalundensis ab (PHAL:Stockholm)
Lund, 223 81
Phone: 46 46 13 27 80
Fax: 46 46 13 27 79www.pharmalundensis.se
|No competitor information is available for PHAL.|
|View Industry Companies|
|Price/Cash Flow||NM||Not Meaningful|
Sponsored Financial Commentaries
To contact PHARMALUNDENSIS AB, please visit www.pharmalundensis.se. Company data is provided by Capital IQ. Please use this form to report any data issues.